• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388

Recent Advances in the Application of (1-Isopropyl-1,2,3,6-tetrahydropyridin-4-YL)boronic acid pinacol ester (CAS: 1642583-50-3) in Chemical Biology and Drug Discovery

The compound (1-Isopropyl-1,2,3,6-tetrahydropyridin-4-YL)boronic acid pinacol ester (CAS: 1642583-50-3) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and versatile applications. This boronic acid ester derivative serves as a critical intermediate in the synthesis of bioactive molecules, particularly in the development of kinase inhibitors and other targeted therapeutics. Recent studies have highlighted its role in Suzuki-Miyaura cross-coupling reactions, a cornerstone methodology in modern drug discovery, enabling the efficient construction of complex molecular architectures.

One of the most notable applications of this compound is its incorporation into proteolysis-targeting chimeras (PROTACs), a groundbreaking therapeutic modality that selectively degrades disease-causing proteins. Researchers have utilized (1-Isopropyl-1,2,3,6-tetrahydropyridin-4-YL)boronic acid pinacol ester as a key building block in the design of novel PROTACs targeting oncogenic kinases. Its boronic acid moiety facilitates stable interactions with target proteins, while the tetrahydropyridine scaffold enhances cellular permeability, addressing a common challenge in PROTAC development.

Recent synthetic methodologies have focused on optimizing the preparation of this compound to improve yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated a streamlined synthetic route starting from commercially available 4-pyridylboronic acid, achieving an overall yield of 78% with excellent enantiomeric purity. This advancement has significant implications for scaling up production to meet the growing demand in preclinical and clinical research.

In pharmacological studies, derivatives of (1-Isopropyl-1,2,3,6-tetrahydropyridin-4-YL)boronic acid pinacol ester have shown promising activity against various cancer cell lines. Particularly, its incorporation into BTK (Bruton's tyrosine kinase) inhibitors has demonstrated enhanced selectivity and potency compared to conventional arylboronic acid derivatives. The isopropyl group at the 1-position appears to confer improved metabolic stability, as evidenced by recent pharmacokinetic studies in rodent models.

Emerging applications in diagnostic imaging have also been reported. The boronic acid functionality allows for facile radiolabeling with fluorine-18, making it a valuable precursor for positron emission tomography (PET) tracers. A recent proof-of-concept study successfully utilized this compound to develop a novel PET probe for imaging neuroinflammation, showcasing its potential beyond therapeutic applications.

Despite these advances, challenges remain in the clinical translation of compounds derived from this scaffold. Current research efforts are focused on addressing potential off-target effects and optimizing the physicochemical properties to improve drug-like characteristics. The development of more water-soluble derivatives without compromising target affinity represents an active area of investigation.

Looking forward, (1-Isopropyl-1,2,3,6-tetrahydropyridin-4-YL)boronic acid pinacol ester continues to be a molecule of significant interest in drug discovery. Its versatility as a synthetic intermediate and unique pharmacological properties position it as a valuable tool in the development of next-generation therapeutics. Ongoing research is expected to further expand its applications, particularly in the areas of targeted protein degradation and precision medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)